Register for our free email digests:
Merck & Co. Inc.
www.merck.com
Latest From Merck & Co. Inc.
Sanofi Improperly Listed Lantus Patent In FDA's Orange Book, Appeals Court Finds
First Circuit reverses dismissal of direct purchasers' suit alleging improper listing of patent on device drive mechanism delayed competition; district court to decide if this constitutes antitrust violation.
Codagenix-Serum Join Fray To Develop SARS-CoV-2 Vaccine
Codagenix, a company backed by Novartis, Merck and the Bill & Melinda Gates Foundation, has tied up with India’s Serum Institute to develop a vaccine against SARS-CoV-2, joining a heated race against the dreaded COVID-19 outbreak.
Deal Watch: Bayer Teams With Nuvisan On Berlin-Based Small Molecule Research Group
Deal news from Bayer, Nuvisan, Inamed, BioMotiv, Bristol-Myers Squibb, Collegium, Assertio, Merck & Co., KalVista, Atreca, Coda, Attenua, Aimmune, Xencor, EyePoint, Equinox, Allergan, Nestle, Zealand, Valeritas…
Keytruda Closing In On First-Line Metastatic Triple-Negative Breast Cancer
An interim analysis of the Phase III KEYNOTE-355 study in triple-negative breast cancer patients reports that first-line pembrolizumab combined with chemotherapy has met the PFS primary endpoint, but Merck & Co is still a long way behind Roche’s Tecentriq in the additional indication.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
- Therapeutic Areas
- Cardiovascular
- Gynecological, Urological
- Infectious & Viral Diseases
- Inflammation
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Ophthalmic
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Merck & Co. Inc.
- Abello SA
- Abmaxis Inc.
- Afferent Pharmaceuticals Inc.
- American Biodyne
- ArQule Inc.
- Assured Health Systems
- Bone Measurement Institute
- BritCair Ltd.
- cCAM Biotherapeutics Ltd.
- Cubist Pharmaceuticals Inc.
- GlycoFi Inc.
- Hangzhou MSD Pharmaceutical Co. Ltd.
- Idenix Pharmaceuticals Inc.
- Inspire Pharmaceuticals Inc.
- IOmet Pharma Ltd.
- Merck BioVentures
- Merck Consumer Healthcare Group
- Merck Frosst Canada Inc.
- Merck Genome Research Institute
- Merck Human Health Division
- Merck Research Laboratories
- Merck Sharp & Dohme Ltd.
- Merck Specialty Chemicals Group
- Merck Vaccine Division
- Merck-Supera Farma JV
- MSD Consumer Care Inc.
- MSD India
- MSD KK
- NovaCardia Inc.
- Oncoethix SA
- Peloton Therapeutics Inc.
- Rigontec GMBH
- Rosetta Inpharmatics LLC
-
Schering-Plough Corp.
- Canji Inc.
- DNAX Research Institute
- Essex Chemie AG
- Integrated Therapeutics Group Inc.
- Key Pharmaceuticals Inc.
- NeoGenesis Pharmaceuticals Inc.
- Organon NV
- Schering Canada
- Schering Corp.
- Schering Laboratories
- Schering-Plough (Brinny) Co.
- Schering-Plough Healthcare Products Inc.
- Schering-Plough Ltd.
- Schering-Plough Pharmaceuticals
- Schering-Plough Research Institute
- Scholl International
- Scholl US Division
- Shanghai Schering-Plough Pharmaceutical Co. Ltd.
- Warrick Pharmaceuticals
- Sibia Neurosciences Inc.
- SmartCells Inc.
- SMSD (Shanghai) Ltd.
- SysteMed Inc.
- Tilos Therapeutics Inc.
- Viralytics Ltd.
- West Point Pharma
- Senior Management
-
Kenneth C Frazier, CEO
Robert M Davis, EVP, CFO
Frank Clyburn, EVP, Chief Commercial Officer - Contact Info
-
Merck & Co. Inc.
Phone: (908) 740-4000
2000 Galloping Hill Rd.
Kenilworth, NJ 07033
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice